Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

General

General

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Crowdsourcing
  • General

If You Had $1,000 Right Now, Would You Put It On Ethereum Or Baby Dogecoin?

By Henry Khederian
August 9, 6:09 PM
Every week, Benzinga conducts a survey to collect sentiment on what traders are most excited about, interested in or thinking about as they manage and build their personal portfolios. This week we posed the following question to over 1,000 Benzinga visitors on cryptocurrency investing:

ETH

Read More
3 minute read
  • Cannabis
  • General
  • Markets
  • News
  • Politics

Cannabis Reg. Updates: Wisconsin Pardons, Delta-8 Hemp Kentucky, Florida Legalization Initiative, NJ Weed Delivery

By Joana Scopel
August 9, 5:43 PM
Wisconsin: More Pardons For Cannabis Offenses

CSE:TRUL

Read More
1 minute read
  • Biotech
  • General

Olema Oncology Advances OP-1250 Into Phase 2 Monotherapy Expansion In Patients With ER+/HER2- Advanced Breast Cancer

By Bill Haddad
August 9, 4:38 PM
SAN FRANCISCO, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (("Olema" or "Olema Oncology, NASDAQ:OLMA), today announced the advancement of OP-1250, a complete estrogen receptor

OLMA

Read More
2 minute read
  • Earnings
  • General
  • Movers
  • News
  • Technicals
  • Top Stories
  • Trading Ideas
  • Travel

Norwegian Cruise Line On ‘PreMarket Prep’: Charting The Plunge

By Joel Elconin
August 9, 3:54 PM
Several issues have rebounded nicely off their pandemic lows only to peak and come back down to levels not seen since mid-2020.

NCLH

Read More
1 minute read
  • Events
  • General
  • Large Cap
  • Media
  • Movers & Shakers
  • News

Ford To Raise Price Of 2023 F-150 Lightning By Up To $8500: Here’s Why

By Dylan Wechsler
August 9, 3:33 PM
On Tuesday, the Ford Motor Company (NYSE: F) announced price hikes to its EV pickup truck, the F-150 Lightning, CNBC reported.

F

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • Downgrades
  • General
  • Health Care
  • Movers
  • News
  • Price Target
  • Small Cap
  • Trading Ideas

Analysts See Softened Timelines For CRISPR Therapeutics’ Sickle Cell Candidate In US

By Vandana Singh
August 9, 3:26 PM
Barclays says that CRISPR Therapeutics AG’s (NASDAQ: CRSP) Q2 FY22 earnings release was largely incremental, highlighting the progress of multiple clinical programs, including the…

BLUE

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • Movers
  • News
  • Trading Ideas

Smiths Acquisition Weighs On ICU Medical’s Profitability, Shares Fall

By Vandana Singh
August 9, 3:15 PM
ICU Medical Inc (NASDAQ:ICUI) reported Q2 sales of $561 million, up 75% Y/Y, due to Smiths Medical’s acquisition, and missing…

ICUI

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Economics
  • Federal Reserve
  • General
  • Markets
  • Topics

BlackRock Says There Is No ‘Soft-Landing’: Central Banks Will Have To Plunge Economy Into A Deep Recession To Stop Inflation

By AJ Fabino
August 9, 3:14 PM
In the current uncertain macroeconomic environment, the world's largest asset manager, BlackRock Inc (NYSE: BLK), predicts there won't be a "soft landing" and prefers overweight investment grade (IG) credit over standard equities.

BLK

Read More
1 minute read
  • General
  • Health Care
  • Media
  • News

FDA Approves New Technique To Extend Supply Of Monkeypox Vaccine: Report

By Michael Cohen
August 9, 3:02 PM
A plan to extend the limited supply of monkeypox vaccine in order to provide additional doses has been approved by the Food and Drug Administration.

BVNRY

Read More
1 minute read
  • Biotech
  • Earnings
  • FDA
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Atara Lays Off 20% Of Its Workforce, Issues Update On Cell Therapies

By Vandana Singh
August 9, 3:01 PM
Atara Biotherapeutics Inc (NASDAQ:ATRA) will reduce cash burn by laying off 20% of its staff and extend the cash…

ATRA

Posts pagination

Previous 1 … 2,249 2,250 2,251 … 2,367 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service